We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Altria Stock Worth Holding as Pricing Offsets Volume Pressure?
Read MoreHide Full Article
Key Takeaways
Altria's pricing helped lift smokeable profit despite lower cigarette volumes in the second quarter.
Discount cigarette shipments jumped 67.3%, as trade-down pressure offset some of Altria's premium pricing.
MO's 6.33% yield and buybacks support the hold case, while its 11.6X multiple tops its five-year median.
Altria Group, Inc. (MO - Free Report) is leaning on pricing, margins and shareholder returns to keep earnings resilient as U.S. cigarette demand declines. Second-quarter results showed that the smokeable business can still convert pricing into profit growth despite lower volumes.
The question is whether that resilience is enough. Trade-down pressure, uneven smoke-free results and a valuation above MO’s five-year median keep the case balanced rather than decisively bullish.
Altria Group, Inc. Price, Consensus and EPS Surprise
Second-quarter smokeable revenues net of excise taxes rose 2%, while adjusted operating companies income increased 2.4% to $3.02 billion. The adjusted operating companies income margin expanded 30 basis points to 64.8%.
Smokeable price realization was 4.5%, led by Marlboro pricing and partly offset by Basic mix. Pricing helped counter lower shipment volume, promotional spending and higher costs, supporting Altria’s narrowed 2026 adjusted earnings guidance of $5.61-$5.72 per share.
MO’s Discount Mix Tests the Pricing Thesis
Domestic cigarette shipments fell 3.2% in the second quarter and an estimated 4.5% after adjusting for trade inventory movements. Industry discount retail share reached 33.8%, up 2.6 percentage points year over year.
Altria’s discount cigarette shipments jumped 67.3%. Basic helps the company compete for value-sensitive smokers, but a larger discount mix partly offsets premium pricing and leaves the earnings model exposed to continued cigarette category contraction.
Altria’s Smoke-Free Push Offers Mixed Signals
Nicotine pouches represented 59.9% of the oral tobacco category, while on!’s retail share of the overall oral market improved to 8.6%. on! PLUS expanded to about 120,000 stores, and first-half on! shipments increased 5.1%.
Still, Oral Tobacco Products revenues fell 5.3% and adjusted operating companies income declined 8%. on!’s nicotine pouch category share fell 1.7 percentage points to 14.4%, showing that category growth does not guarantee share gains.
Philip Morris International Inc. (PM - Free Report) provides a competitive reference point. Its smoke-free business generated 42% of total net revenues in first-half 2026, led by IQOS and ZYN.
British American Tobacco p.l.c. (BTI - Free Report) is another relevant peer. Its first-half 2026 New Categories revenues rose 18%, led by Modern Oral and U.S. vapor.
MO’s Valuation Sits Below Benchmarks but Above Its Median
MO trades at 11.6X forward 12-month earnings, below the Zacks sub-industry’s 15.4X, the Zacks Consumer Staples sector’s 17.2X and the S&P 500’s 20.3X.
That discount is not absolute. Altria’s five-year median multiple is 9.7X, so the stock is priced above its own typical valuation even while screening cheaper than broader benchmarks.
Image Source: Zacks Investment Research
Altria’s Cash Returns Strengthen the Hold Case
Altria paid about $3.6 billion in dividends and repurchased $335 million of shares in the first half of 2026. The company also had $665 million remaining under its repurchase authorization at June 30.
The dividend yield is 6.33%, the payout ratio is 76% and debt to EBITDA stands at 1.9 times. Those metrics support the income case, although they do not remove risks tied to falling cigarette volumes, mix pressure and tobacco regulation.
MO’s Mixed Scores Reinforce a Cautious Stance
Pricing power, cash returns and below-benchmark valuation support a measured hold case, but the premium to Altria’s historical median and structural volume pressure limit the argument for aggressive buying.
MO currently carries a Zacks Rank #3 (Hold), with a VGM Score of C, Value Score of C, Growth Score of C and Momentum Score of D. A Zacks Rank #3 can support holding an existing position, while the C scores are middling and the D Momentum Score is less favorable for near-term trading. Stronger buying setups generally pair a Zacks Rank #1 (Strong Buy) or 2 (Buy) with A or B Style Scores. You can see the complete list of today’s Zacks #1 Rank stocks here.
View the Zacks #1 Rank List
Image: Bigstock
Is Altria Stock Worth Holding as Pricing Offsets Volume Pressure?
Key Takeaways
Altria Group, Inc. (MO - Free Report) is leaning on pricing, margins and shareholder returns to keep earnings resilient as U.S. cigarette demand declines. Second-quarter results showed that the smokeable business can still convert pricing into profit growth despite lower volumes.
The question is whether that resilience is enough. Trade-down pressure, uneven smoke-free results and a valuation above MO’s five-year median keep the case balanced rather than decisively bullish.
Altria Group, Inc. Price, Consensus and EPS Surprise
Altria Group, Inc. price-consensus-eps-surprise-chart | Altria Group, Inc. Quote
Altria’s Pricing Keeps Earnings Resilient
Second-quarter smokeable revenues net of excise taxes rose 2%, while adjusted operating companies income increased 2.4% to $3.02 billion. The adjusted operating companies income margin expanded 30 basis points to 64.8%.
Smokeable price realization was 4.5%, led by Marlboro pricing and partly offset by Basic mix. Pricing helped counter lower shipment volume, promotional spending and higher costs, supporting Altria’s narrowed 2026 adjusted earnings guidance of $5.61-$5.72 per share.
MO’s Discount Mix Tests the Pricing Thesis
Domestic cigarette shipments fell 3.2% in the second quarter and an estimated 4.5% after adjusting for trade inventory movements. Industry discount retail share reached 33.8%, up 2.6 percentage points year over year.
Altria’s discount cigarette shipments jumped 67.3%. Basic helps the company compete for value-sensitive smokers, but a larger discount mix partly offsets premium pricing and leaves the earnings model exposed to continued cigarette category contraction.
Altria’s Smoke-Free Push Offers Mixed Signals
Nicotine pouches represented 59.9% of the oral tobacco category, while on!’s retail share of the overall oral market improved to 8.6%. on! PLUS expanded to about 120,000 stores, and first-half on! shipments increased 5.1%.
Still, Oral Tobacco Products revenues fell 5.3% and adjusted operating companies income declined 8%. on!’s nicotine pouch category share fell 1.7 percentage points to 14.4%, showing that category growth does not guarantee share gains.
Philip Morris International Inc. (PM - Free Report) provides a competitive reference point. Its smoke-free business generated 42% of total net revenues in first-half 2026, led by IQOS and ZYN.
British American Tobacco p.l.c. (BTI - Free Report) is another relevant peer. Its first-half 2026 New Categories revenues rose 18%, led by Modern Oral and U.S. vapor.
MO’s Valuation Sits Below Benchmarks but Above Its Median
MO trades at 11.6X forward 12-month earnings, below the Zacks sub-industry’s 15.4X, the Zacks Consumer Staples sector’s 17.2X and the S&P 500’s 20.3X.
That discount is not absolute. Altria’s five-year median multiple is 9.7X, so the stock is priced above its own typical valuation even while screening cheaper than broader benchmarks.
Image Source: Zacks Investment Research
Altria’s Cash Returns Strengthen the Hold Case
Altria paid about $3.6 billion in dividends and repurchased $335 million of shares in the first half of 2026. The company also had $665 million remaining under its repurchase authorization at June 30.
The dividend yield is 6.33%, the payout ratio is 76% and debt to EBITDA stands at 1.9 times. Those metrics support the income case, although they do not remove risks tied to falling cigarette volumes, mix pressure and tobacco regulation.
MO’s Mixed Scores Reinforce a Cautious Stance
Pricing power, cash returns and below-benchmark valuation support a measured hold case, but the premium to Altria’s historical median and structural volume pressure limit the argument for aggressive buying.
MO currently carries a Zacks Rank #3 (Hold), with a VGM Score of C, Value Score of C, Growth Score of C and Momentum Score of D. A Zacks Rank #3 can support holding an existing position, while the C scores are middling and the D Momentum Score is less favorable for near-term trading. Stronger buying setups generally pair a Zacks Rank #1 (Strong Buy) or 2 (Buy) with A or B Style Scores. You can see the complete list of today’s Zacks #1 Rank stocks here.